Evaristus Chino Ezema , Ngozi Akueme , Precious Okpechi , Omotola Emmanuel , Omosumwen Ede , Sanmi Michael Obe , Ndukaku Ogbonna , Maureen Obi , Nnenna Bessie Emejuru , Ogochukwu Agazie , Vivien Obitulata Ugwu , John Mmaduabuchi , Emmanuel Chiebuka , Valentine Keke , Chinenye Loveth Aleke
{"title":"扩大甲氧氯普胺在迟发性运动障碍中的作用:病例报告","authors":"Evaristus Chino Ezema , Ngozi Akueme , Precious Okpechi , Omotola Emmanuel , Omosumwen Ede , Sanmi Michael Obe , Ndukaku Ogbonna , Maureen Obi , Nnenna Bessie Emejuru , Ogochukwu Agazie , Vivien Obitulata Ugwu , John Mmaduabuchi , Emmanuel Chiebuka , Valentine Keke , Chinenye Loveth Aleke","doi":"10.1016/j.psycr.2024.100238","DOIUrl":null,"url":null,"abstract":"<div><div>Tardive dyskinesia is a medication-induced movement disorder commonly caused by the blockade or depletion of dopamine in the basal ganglia, seen mostly in the psychiatric setting following prolonged use of antipsychotic medications. It is also reported in other settings where patients receive non-antipsychotic medications. The prevalence of tardive dyskinesia varies across age, gender, and race, with women of middle age being more prone to develop tardive dyskinesia more than men. Therefore, we report a case of tardive dyskinesia, post-delivery, in an African woman, who received metoclopramide as part of premedication for spinal anesthesia for an emergency cesarean delivery. The debriefing period following the resolution of the symptoms offered a clue to prior utilization of metoclopramide for the treatment of hyperemesis gravidarum as provided by the patient's family. Hence, fulfilling the diagnostic criteria of prolong usage of the implicating agent.</div></div>","PeriodicalId":74594,"journal":{"name":"Psychiatry research case reports","volume":"3 2","pages":"Article 100238"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expanding the role of metoclopramide in Tardive Dyskinesia: A case report\",\"authors\":\"Evaristus Chino Ezema , Ngozi Akueme , Precious Okpechi , Omotola Emmanuel , Omosumwen Ede , Sanmi Michael Obe , Ndukaku Ogbonna , Maureen Obi , Nnenna Bessie Emejuru , Ogochukwu Agazie , Vivien Obitulata Ugwu , John Mmaduabuchi , Emmanuel Chiebuka , Valentine Keke , Chinenye Loveth Aleke\",\"doi\":\"10.1016/j.psycr.2024.100238\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Tardive dyskinesia is a medication-induced movement disorder commonly caused by the blockade or depletion of dopamine in the basal ganglia, seen mostly in the psychiatric setting following prolonged use of antipsychotic medications. It is also reported in other settings where patients receive non-antipsychotic medications. The prevalence of tardive dyskinesia varies across age, gender, and race, with women of middle age being more prone to develop tardive dyskinesia more than men. Therefore, we report a case of tardive dyskinesia, post-delivery, in an African woman, who received metoclopramide as part of premedication for spinal anesthesia for an emergency cesarean delivery. The debriefing period following the resolution of the symptoms offered a clue to prior utilization of metoclopramide for the treatment of hyperemesis gravidarum as provided by the patient's family. Hence, fulfilling the diagnostic criteria of prolong usage of the implicating agent.</div></div>\",\"PeriodicalId\":74594,\"journal\":{\"name\":\"Psychiatry research case reports\",\"volume\":\"3 2\",\"pages\":\"Article 100238\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry research case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2773021224000348\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry research case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773021224000348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Expanding the role of metoclopramide in Tardive Dyskinesia: A case report
Tardive dyskinesia is a medication-induced movement disorder commonly caused by the blockade or depletion of dopamine in the basal ganglia, seen mostly in the psychiatric setting following prolonged use of antipsychotic medications. It is also reported in other settings where patients receive non-antipsychotic medications. The prevalence of tardive dyskinesia varies across age, gender, and race, with women of middle age being more prone to develop tardive dyskinesia more than men. Therefore, we report a case of tardive dyskinesia, post-delivery, in an African woman, who received metoclopramide as part of premedication for spinal anesthesia for an emergency cesarean delivery. The debriefing period following the resolution of the symptoms offered a clue to prior utilization of metoclopramide for the treatment of hyperemesis gravidarum as provided by the patient's family. Hence, fulfilling the diagnostic criteria of prolong usage of the implicating agent.